跳至主要内容
临床试验/NCT04734392
NCT04734392已完成不适用

Reducing Pacemaker Implantation After TAVR With Modified Implantation Technique

University of Ulm1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2020年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
300
试验地点
1
主要终点
Pacemaker implantation rate

研究概览

简要总结

Hypothesis of the study is that a modified and improved implantation protocol (regarding membranous septum length and implantation depth) will decrease the need for permanent pacemaker stimulation follow TAVR-procedures.

详细描述

Project objectives or hypothesis Hypothesis of the study is that a modified and improved implantation protocol (regarding membranous septum length and implantation depth) will decrease the need for permanent pacemaker stimulation following TAVR-procedures.

Patient profile and sample size The study cohort will comprise of patients referred to transcatheter aortic valve replacement. Patients will be prospectively and consecutively screened and enrolled at a tertiary high-volume center in Germany. TAVR will be performed according to a modified implantation technique regarding membranous septum length. Pacemaker rates will be analyzed and compared to a historical control. Taking into account a contemporary pacemaker rate of 15%, a reduction to 7% will require a sample size of 239 patients per group to achieve statistically significance (Chi-squared test, alpha 0.05, beta 0.80).

Regarding the prospective cohort, interims analysis will be performed after each 10 TAVR procedures. In case a signal towards worse outcomes with the modified implantation technique will be observed, the institutional safety and endpoint adjudication committee will stop further execution of the study.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients referred to TAVR procedure due to severe aortic stenosis

排除标准

  • PM-implantation before TAVR
  • Valve-in-valve procedures

结局指标

主要结局

Pacemaker implantation rate

时间窗: Day 5 after TAVR

Primary endpoint

次要结局

  • Extent of paravalvular leak(Day 5 after TAVR)
  • Number of patients alive(30 days)

研究者

发起方
University of Ulm
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Dominik Buckert

PD Dr. Dominik Buckert, MD

University of Ulm

研究点 (1)

Loading locations...

相似试验